Please assess the completion status of the following clinical trial:

Trial Title: Infantile Colic: Study of the Efficacy of Lactobacillus GG (ATCC 53103) Plus Chamomile in Breastfeeding Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Caregiver is able to give written informed assent and willingness to participate in the study and comply with its procedures~* Male or Female~* Born at term (38-41 weeks gestation)~* Aged 3 wks-16 wks~* Be in generally good health as determined by the investigators~* BMI between 5th and 95th percentiles~* Exclusively breastfeeding throughout the study~* Be willing to complete crying diary~* Be willing to administer the probiotic as prescribed~* Be willing to completed the Quality of Life instrument before and after the intervention~* Meets the Rome criteria for colic~Exclusion Criteria:~* Are less than 3 weeks or greater than 17 weeks of age or older~* Underweighted or obese based on BMI. Less than 5th or greater than 95th percentiles~* Mothers on an exclusively vegan diet and those with a chronic disease requiring medication therapy~* Mothers or infants having a significant acute or chronic existing illness \[cardiovascular, gastrointestinal, immunological\] or a condition, which in the investigators judgment contraindicates involvement in the study~* Mothers or infants having a condition or taking a medication, dietary supplement or food product that the investigator believes would interfere with the objectives of the study pose a safety risk or confound the interpretation of the study results~* Individuals who, in the opinion of the investigator, are considered to be poor clinical attendees or unlikely for any reason to be able to comply with the trial~* Mothers or infants who are receiving treatment involving experimental drugs~* Participation in a recent experimental trial less than 30 days prior to this study~* Inability to complete the diary, survey scales and appointments~* First degree relative allergic to ragweed, asters, or chrysanthemums~* The following concomitant medications are not allowed at any time during or 1 week prior to initiation of the study: antibiotics or probiotics

- Gender: ALL
- Minimum Age: 3 Weeks
- Maximum Age: 16 Weeks
- Healthy Volunteers: f

Study Arms:
- chamomile/probiotic arm (Type: EXPERIMENTAL): Infant will receive 5 drops of the study product once per day with a feeding at midday.
- Placebo of chamomile/probiotic arm (Type: PLACEBO_COMPARATOR): Infant will receive 5 drops of a placebo product once a day at midday.

Based on this trial design, predict the completion outcome and termination type (if applicable).